Skip to content
OpenCapital
Get started

CareDx CDNA Sales & Marketing

Sales & Marketing at other companies

NeoGenomics logo
NeoGenomicsNEO
$23.83M+5.1%
Veracyte logo
VeracyteVCYT
$27.16M+11.0%
Guardant Health logo
Guardant HealthGH
$169.13M+62.1%
Teladoc Health logo
Teladoc HealthTDOC
$151.53M-9.9%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%—
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's sales & marketing?
CareDx (CDNA) reported sales & marketing of $30.37M in Q1 2026.
How has CareDx's sales & marketing changed year-over-year?
CareDx's sales & marketing increased by 32.1% year-over-year, from $22.99M to $30.37M.
What is the long-term trend for CareDx's sales & marketing?
Over 4 years (2021 to 2025), CareDx's sales & marketing has grown at a 7.4% compound annual growth rate (CAGR), from $77.25M to $102.64M.
What does sales & marketing mean?
Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.